神经血管设备市场－全球产业规模、份额、趋势、机会和预测（按设备、治疗应用、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球神经血管器械市场价值为 74.8 亿美元，预计到 2030 年将达到 105.2 亿美元，复合年增长率为 5.82%。由于中风、动脉瘤和动静脉畸形等神经血管疾病的发生率不断上升，该市场正在迅速扩张。随着医疗系统优先考虑早期干预，对能够促进快速微创治疗的先进神经血管技术的需求日益增长。影像、导管系统和支架检索方法的技术进步显着提高了患者的治疗效果和手术效率。医疗专业人员和患者对微创手术益处的认识不断提高，也促进了微创手术的广泛应用。此外，老龄人口的增长使老年人更容易患神经系统疾病，这进一步推动了对能够促进更快康復和降低手术风险的专用神经血管解决方案的需求。

关键市场驱动因素

中风和神经血管疾病发生率上升

主要市场挑战

设备和手术成本高昂

主要市场趋势

人工智慧 (AI) 和影像引导导航的采用率不断上升

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球神经血管设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依设备（脑栓塞及动脉瘤栓塞装置、脑血管成形术及支架系统、神经血栓切除术设备、支援设备、经桡动脉连接设备）
  • 依治疗应用（中风、脑动脉、脑动脉瘤、其他）
  • 按最终使用者（医院、专科诊所、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美神经血管设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲神经血管设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太神经血管器械市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲神经血管设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲神经血管设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Medtronic plc
• Stryker Corporation
• Terumo Corporation
• Penumbra, Inc.
• Johnson & Johnson Services, Inc.
• Integra LifeSciences Corporation
• Acandis GmbH
• Spiegelberg GmbH & Co. KG
• MicroPort Scientific Corporation
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Neurovascular Devices Market was valued at USD 7.48 Billion in 2024 and is projected to reach USD 10.52 Billion by 2030, growing at a CAGR of 5.82%. This market is expanding rapidly, fueled by the increasing prevalence of neurovascular conditions such as strokes, aneurysms, and arteriovenous malformations. As medical systems prioritize early intervention, there is a growing need for advanced neurovascular technologies that facilitate prompt and minimally invasive treatments. Technological progress in imaging, catheter systems, and stent retrieval methods has significantly enhanced patient outcomes and procedural efficiency. Rising awareness among healthcare professionals and patients regarding the benefits of minimally invasive procedures is also contributing to broader adoption. Additionally, the growing elderly population, which is more prone to neurological ailments, is further driving demand for specialized neurovascular solutions that promote faster recovery and reduce surgical risks.

Key Market Drivers

Rising Incidence of Stroke and Neurovascular Disorders

The increasing frequency of strokes and related neurovascular disorders is a major force behind the market's growth. Globally, strokes remain a leading cause of mortality and long-term disability, with over 12 million first-time stroke cases reported each year and around 6.5 million resulting in death, according to the World Stroke Organization. A significant proportion of these cases affect individuals under 70, and even a growing number under 50, underscoring the widespread nature of the issue. This surge in neurological conditions has accelerated the demand for prompt, minimally invasive interventions using advanced devices such as thrombectomy catheters, flow diverters, and embolization coils. These tools are essential for quickly restoring cerebral blood flow and reducing damage, ultimately leading to improved recovery outcomes. Furthermore, increased investment in specialized stroke centers and neurointervention capabilities is ensuring broader access to high-performance devices and timely care.

Key Market Challenges

High Cost of Devices and Procedures

The substantial cost associated with neurovascular devices and procedures remains a critical obstacle for the market. Products like stent retrievers, embolization coils, and flow diverters involve complex engineering and premium materials, which contribute to their elevated prices. For example, a Pipeline Embolization Device can cost upwards of USD 27,000, and the comprehensive cost of mechanical thrombectomy per patient often exceeds USD 285,000. These financial demands are compounded by the need for specialized imaging systems, trained professionals, and extended care, further inflating treatment expenses. Access is particularly constrained in low- and middle-income countries, while reimbursement inconsistencies in developed markets can also deter adoption. The financial burden on healthcare systems and patients continues to challenge the broader implementation of advanced neurovascular solutions.

Key Market Trends

Rising Adoption of Artificial Intelligence (AI) and Image-Guided Navigation

A prominent trend shaping the neurovascular devices market is the growing incorporation of Artificial Intelligence (AI) and image-guided navigation technologies. These innovations are enhancing diagnostic and procedural precision by enabling real-time visualization and data-driven decision-making. AI systems assist in the rapid interpretation of complex imaging data, improving detection and treatment planning for conditions such as aneurysms and strokes. Image-guided navigation facilitates safer and more effective placement of devices like stents and catheters by offering detailed vascular mapping. The integration of AI with high-resolution imaging technologies-such as MRI and CT angiography-not only supports personalized treatment strategies but also predicts outcomes and identifies risks before procedures begin. These advancements are streamlining workflows, reducing error rates, and promoting better clinical results, while continued investments in AI-driven platforms are expected to further accelerate innovation and adoption.

Key Market Players

• Medtronic plc
• Stryker Corporation
• Terumo Corporation
• Penumbra, Inc.
• Johnson & Johnson Services, Inc.
• Integra LifeSciences Corporation
• Acandis GmbH
• Spiegelberg GmbH & Co. KG
• MicroPort Scientific Corporation
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Report Scope

In this report, the Global Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurovascular Devices Market, By Device:

• Cerebral Embolization and Aneurysm Coiling Devices
• Cerebral Angioplasty and Stenting Systems
• Neurothrombectomy Devices
• Support Devices
• Trans Radial Access Devices

Neurovascular Devices Market, By Therapeutic Application:

• Stroke
• Cerebral Artery
• Cerebral Aneurysm
• Others

Neurovascular Devices Market, By End User:

• Hospitals
• Specialty Clinics
• Others

Neurovascular Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurovascular Devices Market.

Available Customizations

Global Neurovascular Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Neurovascular Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices)
  • 5.2.2. By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Neurovascular Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device
  • 6.2.2. By Therapeutic Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neurovascular Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device
      • 6.3.1.2.2. By Therapeutic Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Neurovascular Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device
      • 6.3.2.2.2. By Therapeutic Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Neurovascular Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device
      • 6.3.3.2.2. By Therapeutic Application
      • 6.3.3.2.3. By End User

7. Europe Neurovascular Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device
  • 7.2.2. By Therapeutic Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Neurovascular Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device
      • 7.3.1.2.2. By Therapeutic Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Neurovascular Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device
      • 7.3.2.2.2. By Therapeutic Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Neurovascular Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device
      • 7.3.3.2.2. By Therapeutic Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Neurovascular Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device
      • 7.3.4.2.2. By Therapeutic Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Neurovascular Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device
      • 7.3.5.2.2. By Therapeutic Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Neurovascular Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device
  • 8.2.2. By Therapeutic Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Neurovascular Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device
      • 8.3.1.2.2. By Therapeutic Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Neurovascular Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device
      • 8.3.2.2.2. By Therapeutic Application
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Neurovascular Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device
      • 8.3.3.2.2. By Therapeutic Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Neurovascular Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device
      • 8.3.4.2.2. By Therapeutic Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Neurovascular Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device
      • 8.3.5.2.2. By Therapeutic Application
      • 8.3.5.2.3. By End User

9. South America Neurovascular Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device
  • 9.2.2. By Therapeutic Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Neurovascular Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device
      • 9.3.1.2.2. By Therapeutic Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Neurovascular Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device
      • 9.3.2.2.2. By Therapeutic Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Neurovascular Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device
      • 9.3.3.2.2. By Therapeutic Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Neurovascular Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device
  • 10.2.2. By Therapeutic Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Neurovascular Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device
      • 10.3.1.2.2. By Therapeutic Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Neurovascular Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device
      • 10.3.2.2.2. By Therapeutic Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Neurovascular Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device
      • 10.3.3.2.2. By Therapeutic Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Stryker Corporation
• 15.3. Terumo Corporation
• 15.4. Penumbra, Inc.
• 15.5. Johnson & Johnson Services, Inc.
• 15.6. Integra LifeSciences Corporation
• 15.7. Acandis GmbH
• 15.8. Spiegelberg GmbH & Co. KG
• 15.9. MicroPort Scientific Corporation
• 15.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

16. Strategic Recommendations

17. About Us & Disclaimer